We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Medigene Acquires Trianta Immunotherapies

News   Jan 28, 2014

 
Medigene Acquires Trianta Immunotherapies
 
 
 

RELATED ARTICLES

Bacterial ‘Sleeper Cells’ Evade Antibiotics and Weaken Defence Against Infection

News

These bacteria persister cells stop replicating and can remain in this dormant, ‘sleeper-cell’ state for days, weeks or even months. When antibiotic treatment has been stopped, if some of these bacterial cells spring back to life, they can trigger another infection.

READ MORE

From Fibroblast to Antigen-presenting Dendritic Cell: a Pioneering Approach

News

Direct programming of mouse and human skin cells into antigen-presenting dendritic cells opens up the possibility of developing novel dendritic cell-based immunotherapies against cancer.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE